German Ifo Business Confidence Brightens In March

Business confidence in Germany improved in March on stronger expectations and better assessment of the current conditions, survey results from the ifo Institute showed on Friday. The business sentiment index rose more-than-expected to 87.8 from an upwardly revised 85.7 in February. The score was forecast to climb to 86.0. Moreover, this was the highest score...

Read More

HTX Ex-Employees Sentenced to 3 Years for Stealing 27,000 Mnemonics and 10,000 User Private Keys

In a recent revelation, Chinese police disclosed that four former employees of HTX (formerly Huobi) were involved in implanting Trojans in cryptocurrency wallets, resulting in the theft of over 40,000 user mnemonics and private keys. The individuals responsible have been sentenced to three years in prison, although the specific amount of stolen cryptocurrencies remains undisclosed....

Read More

Paramount Global To Merge With Skydance; Stock Up

Media major Paramount Global and Skydance Media, founded by David Ellison, son of Oracle founder Larry Ellison, announced late Sunday their agreement to merge in an all-stock transaction, to form New Paramount at an enterprise value of around $28 billion. In pre-market activity on the Nasdaq, Paramount Global shares were gaining around 4.7 percent to...

Read More

Aerovate Says Phase 2b Portion Of Trial Of AV-101 Fails To Meet Primary And Secondary Endpoints

Biopharmaceutical company Aerovate Therapeutics, Inc. (AVTE) announced Monday topline results from the Phase 2b portion of the Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial (IMPAHCT), a Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multi-national trial of AV-101. AV-101 is a novel dry powder inhaled formulation of imatinib, in adults with pulmonary arterial hypertension (PAH). The objective...

Read More